The suggestion is "followed by label extension in the larger adult population".
We don't know how that label extension would be approved, but it is a shorter pathway than another full BLA for adult GVHD, hence potential saving and quicker time to market. But, it does not mean no additional study or trial for adult GVHD.
ASX Hot too!, page-373
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
94.0¢ |
Change
-0.020(2.08%) |
Mkt cap ! $1.090B | |||
| Open | High | Low | Value | Volume |
| 95.5¢ | 97.0¢ | 94.0¢ | $552.4K | 580.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 17 | 66138 | 94.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 94.5¢ | 55899 | 52 |
View Market Depth
| Last trade - 12.02pm 13/09/2024 (20 minute delay) ? |
| MSB (ASX) Chart |